These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37809473)

  • 21. Developing Patient-Centered Real-World Evidence: Emerging Methods Recommendations From a Consensus Process.
    Oehrlein EM; Schoch S; Burcu M; McBeth JF; Bright J; Pashos CL; Willke R; Love TR; Mattingly TJ; Perfetto EM;
    Value Health; 2023 Jan; 26(1):28-38. PubMed ID: 35863944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of real-world evidence in meta-analyses and cost-effectiveness models.
    Bowrin K; Briere JB; Levy P; Toumi M; Millier A
    J Med Econ; 2020 Oct; 23(10):1053-1060. PubMed ID: 32657189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How do cancer clinicians perceive real-world data and the evidence derived therefrom? Findings from an international survey of the European Organisation for Research and Treatment of Cancer.
    Saesen R; Kantidakis G; Marinus A; Lacombe D; Huys I
    Front Pharmacol; 2022; 13():969778. PubMed ID: 36091761
    [No Abstract]   [Full Text] [Related]  

  • 24. AMCP Partnership Forum: Improving Quality, Value, and Outcomes with Patient-Reported Outcomes.
    J Manag Care Spec Pharm; 2018 Mar; 24(3):304-310. PubMed ID: 29460679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrating the use of patient-reported outcomes for both clinical practice and performance measurement: views of experts from 3 countries.
    Van Der Wees PJ; Nijhuis-Van Der Sanden MW; Ayanian JZ; Black N; Westert GP; Schneider EC
    Milbank Q; 2014 Dec; 92(4):754-75. PubMed ID: 25492603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real world evidence (RWE) - a disruptive innovation or the quiet evolution of medical evidence generation?
    Khosla S; White R; Medina J; Ouwens M; Emmas C; Koder T; Male G; Leonard S
    F1000Res; 2018; 7():111. PubMed ID: 30026923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring unique device identifier implementation and use for real-world evidence: a mixed-methods study with NESTcc health system network collaborators.
    Dhruva SS; Ridgeway JL; Ross JS; Drozda JP; Wilson NA
    BMJ Surg Interv Health Technol; 2023; 5(1):e000167. PubMed ID: 36704544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of Clinical Data Interchange Standards Consortium (CDISC) Standards for Real-world Data: Expert Perspectives From a Qualitative Delphi Survey.
    Facile R; Muhlbradt EE; Gong M; Li Q; Popat V; Pétavy F; Cornet R; Ruan Y; Koide D; Saito TI; Hume S; Rockhold F; Bao W; Dubman S; Jauregui Wurst B
    JMIR Med Inform; 2022 Jan; 10(1):e30363. PubMed ID: 35084343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders.
    Cruz Rivera S; McMullan C; Jones L; Kyte D; Slade A; Calvert M
    J Patient Rep Outcomes; 2020 Jul; 4(1):51. PubMed ID: 32617713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can we use existing guidance to support the development of robust real-world evidence for health technology assessment/payer decision-making?
    Capkun G; Corry S; Dowling O; Asad Zadeh Vosta Kolaei F; Takyar S; Furtado C; Jónsson P; Kleinermans D; Lambert L; Schiel A; Facey K
    Int J Technol Assess Health Care; 2022 Nov; 38(1):e79. PubMed ID: 36321447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial stewardship programme implementation in the UAE: perspectives of key stakeholders using Consolidated Framework for Implementation Research.
    Hashad N; Stewart D; Perumal D; Abdulrazzaq N; Tonna AP
    J Hosp Infect; 2023 Jul; 137():69-76. PubMed ID: 37211094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium guidance.
    Banerjee AK; Okun S; Edwards IR; Wicks P; Smith MY; Mayall SJ; Flamion B; Cleeland C; Basch E;
    Drug Saf; 2013 Dec; 36(12):1129-49. PubMed ID: 24092596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia.
    Webster J; Smith BD
    Clin Ther; 2019 Feb; 41(2):336-349. PubMed ID: 30709609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration.
    Chan K; Nam S; Evans B; de Oliveira C; Chambers A; Gavura S; Hoch J; Mercer RE; Dai WF; Beca J; Tadrous M; Isaranuwatchai W
    BMJ Open; 2020 Jan; 10(1):e032884. PubMed ID: 31915169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Healthcare stakeholders' perceptions and experiences of factors affecting the implementation of critical care telemedicine (CCT): qualitative evidence synthesis.
    Xyrichis A; Iliopoulou K; Mackintosh NJ; Bench S; Terblanche M; Philippou J; Sandall J
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD012876. PubMed ID: 33599282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-World Evidence: A Primer.
    Dang A
    Pharmaceut Med; 2023 Jan; 37(1):25-36. PubMed ID: 36604368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transparency in real-world evidence (RWE) studies to build confidence for decision-making: Reporting RWE research in diabetes.
    Patorno E; Schneeweiss S; Wang SV
    Diabetes Obes Metab; 2020 Apr; 22 Suppl 3(Suppl 3):45-59. PubMed ID: 32250527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integration of real-world evidence from different data sources in health technology assessment.
    Graili P; Guertin JR; Chan KKW; Tadrous M
    J Pharm Pharm Sci; 2023; 26():11460. PubMed ID: 37529633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A medicine adoption model for assessing the expected effects of additional real-world evidence (RWE) at product launch.
    Jandhyala R
    Curr Med Res Opin; 2021 Sep; 37(9):1645-1655. PubMed ID: 34176383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reality check: Real-world evidence to support therapeutic development in hematologic malignancies.
    Derman BA; Belli AJ; Battiwalla M; Hamadani M; Kansagra A; Lazarus HM; Wang CK
    Blood Rev; 2022 May; 53():100913. PubMed ID: 35272867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.